Rakesh Ganguly
Overview
Explore the profile of Rakesh Ganguly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pragti , Nayek S, Singh S, Sonawane A, Grabchev I, Ganguly R, et al.
Dalton Trans
. 2023 May;
52(21):7104-7118.
PMID: 37158792
Recently in the field of chemotherapeutics, to combat the side effects of cisplatin, ruthenium complexes have been investigated extensively. In this work, a bidentate benzimidazole-based ligand, HL [HL = 2-(1-benzo[]imidazol-2-yl)-6-methoxyphenol],...
2.
Size-control in the synthesis of oxo-bridged phosphazane macrocycles via a modular addition approach
Shi X, Leon F, Ong H, Ganguly R, Diaz J, Garcia F
Commun Chem
. 2023 Jan;
4(1):21.
PMID: 36697582
Inorganic macrocycles remain largely underdeveloped compared with their organic counterparts due to the challenges involved in their synthesis. Among them, cyclodiphosphazane macrocycles have shown to be promising candidates for supramolecular...
3.
Sim Y, Leon F, Hum G, Phang S, Ong H, Ganguly R, et al.
Commun Chem
. 2023 Jan;
5(1):59.
PMID: 36697579
Inorganic macrocycles remain challenging synthetic targets due to the limited number of strategies reported for their syntheses. Among these species, large fully inorganic cyclodiphosphazane macrocycles have been experimentally and theoretically...
4.
Lai J, Maah M, Tan K, Sarip R, Lim Y, Ganguly R, et al.
Malar J
. 2022 Dec;
21(1):386.
PMID: 36528584
Background: Malaria remains one of the most virulent and deadliest parasitic disease in the world, particularly in Africa and Southeast Asia. Widespread occurrence of artemisinin-resistant Plasmodium falciparum strains from the...
5.
Ranjan R, Chakraborty A, Kyarikwal R, Ganguly R, Mukhopadhyay S
Dalton Trans
. 2022 Aug;
51(35):13288-13300.
PMID: 35983724
Visible-light driven photoreactions using transition metal complexes as catalysts are currently a research hotspot in developing environmentally friendly sustainable processes. To develop a potential copper-based photocatalyst, a binuclear Cu(II) complex...
6.
Pragti , Kundu B, Upadhyay S, Sinha N, Ganguly R, Grabchev I, et al.
Dalton Trans
. 2022 Feb;
51(10):3937-3953.
PMID: 35171173
Ruthenium complexes are being studied extensively as anticancer drugs following the inclusion of NAMI-A and KP1019 in phase II clinical trials for the treatment of metastatic phase and primary tumors....
7.
Kong J, Lam Z, Chan K, Ganguly R, Lee J, Loo L, et al.
ACS Omega
. 2021 Nov;
6(43):29045-29053.
PMID: 34746593
A set of metal carbonyl cluster-boronic acid conjugates of the group VIII metals (Fe, Ru, and Os) were synthesized and their antiproliferative effects measured against two breast cancer cell lines...
8.
Ng Z, Tan D, Teo W, Leon F, Shi X, Sim Y, et al.
Angew Chem Int Ed Engl
. 2021 May;
60(32):17481-17490.
PMID: 33982390
The ability to rationally design and predictably construct crystalline solids has been the hallmark of crystal engineering research. To date, numerous examples of multicomponent crystals comprising organic molecules have been...
9.
Courte M, Ye J, Jiang H, Ganguly R, Tang S, Kloc C, et al.
Phys Chem Chem Phys
. 2020 Aug;
22(35):19855-19863.
PMID: 32851393
Polymorphism is a central phenomenon in materials science that often results in important differences of the electronic properties of organic crystals due to slight variations in intermolecular distances and positions....
10.
Shi X, Leon F, Sim Y, Quek S, Hum G, Khoo Y, et al.
Angew Chem Int Ed Engl
. 2020 Jul;
59(49):22100-22108.
PMID: 32696527
We have synthesized a completely new family of acyclic trimeric cyclodiphosphazane compounds comprising NH, N Pr, N Bu and NPh bridging groups. In addition, the first NH-bridged acyclic dimeric cyclophosphazane...